Effects of Intraperitoneal Injection of Galanin on c-Fos Expression in the Brain in Wistar Rats Receiving Intragastric Administration of HCl
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-02-01
著者
-
Hayashi Kaori
Department Of Biochemistry Akita University School Of Medicine
-
Takayama Kiyoshige
Department Of Laboratory Sciences Gunma University School Of Health Sciences
-
Takayama Kiyoshige
Department Of Laboratory Sciences Gunma University School Of Health Science
-
Hayashi Kaori
Department Of Laboratory Sciences Gunma University School Of Health Sciences
関連論文
- REG I enhances chemo- and radiosensitivity in squamous cell esophageal cancer cells
- Cervical Approach for Resection of a Pedunculated Giant Atypical Lipomatous Tumor of the Esophagus
- Prevention and regression of hypertension : role of renal microvascular protection
- Five cases of necrotizing fasciitis : Lack of skin inflammatory signs as a clinical clue for the fulminant type
- Comparison of the actions of acylated and desacylated ghrelin on acid secretion in the rat stomach
- Neuronal expression of c-Fos protein in the brain after intraperitoneal injection of apelin-12 in Wistar rats
- Changes in Neuronal Expression of c-Fos Protein in the Medulla Oblongata after Unilateral Phrenicotomy in Wistar Rats
- Effects of Intraperitoneal Injection of Galanin on c-Fos Expression in the Brain in Wistar Rats Receiving Intragastric Administration of HCl
- Epidemiology of hip fractures in Okinawa, Japan
- Distribution and projection of the medullary cardiovascular control neurons containing glutamate, glutamic acid decarboxylase, tyrosine hydroxylase and phenylethanolamine N-methyltransferase in rats
- Effects of Apelin-12 on Respiration in Wistar Rats
- Cardiovascular responses to apelin-12 injection into the ventral medullary surface in rats
- Difference in Hypotensive Effect of Apelin-12 between Spontaneously Hypertensive Rat and Normotensive Wistar Kyoto Rat
- Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy
- Depression in Patients with Subacute Myelo-Optico- Neuropathy (SMON)